Correlation Between Cardio Diagnostics and Castle Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Castle Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Castle Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Castle Biosciences, you can compare the effects of market volatilities on Cardio Diagnostics and Castle Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Castle Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Castle Biosciences.

Diversification Opportunities for Cardio Diagnostics and Castle Biosciences

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Cardio and Castle is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Castle Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Castle Biosciences and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Castle Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Castle Biosciences has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Castle Biosciences go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and Castle Biosciences

Assuming the 90 days horizon Cardio Diagnostics Holdings is expected to generate 5.34 times more return on investment than Castle Biosciences. However, Cardio Diagnostics is 5.34 times more volatile than Castle Biosciences. It trades about 0.02 of its potential returns per unit of risk. Castle Biosciences is currently generating about -0.07 per unit of risk. If you would invest  7.15  in Cardio Diagnostics Holdings on January 24, 2025 and sell it today you would lose (3.21) from holding Cardio Diagnostics Holdings or give up 44.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy91.94%
ValuesDaily Returns

Cardio Diagnostics Holdings  vs.  Castle Biosciences

 Performance 
       Timeline  
Cardio Diagnostics 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cardio Diagnostics Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Cardio Diagnostics showed solid returns over the last few months and may actually be approaching a breakup point.
Castle Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Castle Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in May 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Cardio Diagnostics and Castle Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardio Diagnostics and Castle Biosciences

The main advantage of trading using opposite Cardio Diagnostics and Castle Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Castle Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Castle Biosciences will offset losses from the drop in Castle Biosciences' long position.
The idea behind Cardio Diagnostics Holdings and Castle Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like